Stock Updates

How has Gilead Sciences Inc.:(NASDAQ:GILD) performed recently?

Gilead Sciences Inc. (NASDAQ: GILD) is a large market cap stock with a market cap of 103555.95. It is in the Biotechnology industry and sector Healthcare, with a current P/E of 6.83, a forward P/E of 6.72 and EPS of 11.35. At a stock price of 77.57 (0.43%) it has a dividend yield of 2.42%.

EPS growth for the last five years have been 48.30%, more recently this last year it has grown by 62.00%. The next year growth is going to be about -1.79% and more long-term -0.21% after five years. EPS growth quarter over quarter is -11.50%. Sales growth for the past five years have been 32.60% and sales growth quarter over quarter is -5.70%.

For performance, Gilead Sciences Inc. the past week has seen a gain of -1.77%. For the last month performance for Gilead Sciences Inc. is 0.21%. While the last quarter is -8.69% and half year, -17.88%. Finally for the year, performance is -18.80%.

The 52-week high for Gilead Sciences Inc., is at -28.72%, and for the 52-week low it comes to a value of 1.79%. The 20-day simple moving average is -2.03% and -10.18% for the 200-day simple moving average.

Volatility for the week is at 1.80%, and for the month it is 1.60%. Gilead Sciences Inc., has a target price of 103.5.

In terms of debt, long term debt/equity is 1.38, and for total debt/equity Gilead Sciences Inc. has 1.42. The gross margin is 87.10%, while operating margin is 63.00%, the profit margin is 50.50%. The current ratio is 1.8 and the quick ratio is 1.6.

Insider ownership is at 0.40%, with instituitional ownership at 80.50%. Gilead Sciences Inc. has a payout ratio of 15.20%. With the total shares outstanding coming to 1335. The shares float is 1311.57, with the float short at 1.10%, with short ratio coming to 1.38.

In terms of returns, the return on assets see Gilead Sciences Inc., get 32.70%, with its returns on investment at 45.90%. Return on equity is 100.80%. So will the investors see the target price of 103.5, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Peter Clarke

Leave a Comment